Skip to main navigation Skip to search Skip to main content

How has the management of medullary thyroid carcinoma changed with the advent of 18F-FDG and non-18F-FDG PET radiopharmaceuticals

  • Ka Kit Wong
  • , Amanda M. Laird
  • , Amir Moubayed
  • , Sotirios Chondrogiannis
  • , Maria Cristina Marzola
  • , Laura Evangelista
  • , Milton D. Gross
  • , Domenico Rubello
  • University of Michigan
  • Veterans Health Administration
  • Santa Maria della Misericordia Hospital
  • IRCCS Istituto Oncologico Veneto - Padova

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalNuclear Medicine Communications
Volume33
Issue number7
DOIs
StatePublished - Jul 1 2012
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Radiology

Cite this